| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 SLC9A9 SLCO4A1 SLC25A30 SLC10A3 SLC30A3 SLC9C2 SLC1A6 ABCA8 CLCN5 ABCB9 SLC22A1 ATP2C2 SLC22A10 SLC39A6 ABCC12 SLC24A1 | 1.74e-08 | 477 | 132 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC1 SLC9A9 SLC25A33 SLCO4A1 SLC25A30 SLC10A3 FLVCR2 OTOP3 SLC22A24 SLC30A3 SLC9C2 AQP5 SLC1A6 ABCA8 CLCN1 CLCN5 ABCB9 SLC22A1 ATP2C2 SLC22A10 PKD1 SLC39A6 ABCC12 SLC24A1 SLC14A2 | 1.99e-07 | 1180 | 132 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | NPC1 ABCC1 SLC9A9 SLC25A33 SLCO4A1 SLC25A30 SLC10A3 FLVCR2 OTOP3 SLC22A24 SLC30A3 SLC9C2 AQP5 SLC1A6 ABCA8 CLCN1 CLCN5 ABCB9 SLC22A1 ATP2C2 SLC22A10 PKD1 SLC39A6 ABCC12 SLC24A1 SLC14A2 | 2.82e-07 | 1289 | 132 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC9A9 SLCO4A1 SLC25A30 SLC10A3 SLC30A3 SLC9C2 SLC1A6 CLCN5 SLC22A1 SLC22A10 SLC39A6 SLC24A1 | 6.46e-07 | 296 | 132 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | omega peptidase activity | 3.12e-06 | 16 | 132 | 4 | GO:0008242 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 5.57e-06 | 6 | 132 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 5.57e-06 | 6 | 132 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 8.14e-06 | 20 | 132 | 4 | GO:0070003 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 1.54e-05 | 8 | 132 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 2.30e-05 | 9 | 132 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 SLC9A9 SLC25A30 SLC10A3 OTOP3 SLC30A3 SLC9C2 AQP5 SLC1A6 CLCN1 CLCN5 SLC22A1 ATP2C2 PKD1 SLC39A6 SLC24A1 | 4.13e-05 | 758 | 132 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 4.34e-05 | 2 | 132 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 4.34e-05 | 2 | 132 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 4.34e-05 | 2 | 132 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 4.34e-05 | 2 | 132 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.23e-04 | 73 | 132 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 2.53e-04 | 19 | 132 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | palmitoyl-CoA oxidase activity | 2.58e-04 | 4 | 132 | 2 | GO:0016401 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.07e-04 | 49 | 132 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | antiporter activity | 3.14e-04 | 138 | 132 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.31e-04 | 196 | 132 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 7.57e-04 | 62 | 132 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 7.89e-04 | 109 | 132 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 8.90e-04 | 301 | 132 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | L-leucine binding | 8.91e-04 | 7 | 132 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | acyl-CoA oxidase activity | 8.91e-04 | 7 | 132 | 2 | GO:0003997 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.72e-04 | 171 | 132 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC9A9 SLC10A3 SLC30A3 SLC9C2 SLC1A6 SLC22A1 ATP2C2 PKD1 SLC39A6 SLC24A1 | 1.06e-03 | 465 | 132 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.45e-03 | 34 | 132 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 1.89e-03 | 10 | 132 | 2 | GO:0016634 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.29e-03 | 11 | 132 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC9A9 SLC10A3 OTOP3 SLC30A3 SLC9C2 SLC1A6 CLCN1 CLCN5 SLC22A1 ATP2C2 PKD1 SLC39A6 SLC24A1 | 2.31e-03 | 793 | 132 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.69e-03 | 42 | 132 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor | 2.74e-03 | 12 | 132 | 2 | GO:0052890 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 2.74e-03 | 12 | 132 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | acyl-CoA dehydrogenase activity | 2.74e-03 | 12 | 132 | 2 | GO:0003995 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 2.87e-03 | 43 | 132 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC9A9 SLC10A3 OTOP3 SLC30A3 SLC9C2 SLC1A6 SLC22A1 ATP2C2 PKD1 SLC39A6 SLC24A1 | 3.01e-03 | 627 | 132 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 3.07e-03 | 44 | 132 | 3 | GO:0046915 | |
| GeneOntologyMolecularFunction | symporter activity | 3.22e-03 | 150 | 132 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | palmitoyl-(protein) hydrolase activity | 3.23e-03 | 13 | 132 | 2 | GO:0008474 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.38e-03 | 293 | 132 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 ADGRG5 OR5T1 OR7A5 NTRK1 MFSD6 OR1F2P CASR OR8H1 OR14C36 CR1 OR10Z1 OR1N2 NRXN1 PKD1 MTNR1A TAS1R2 PLXNA2 | 3.49e-03 | 1353 | 132 | 18 | GO:0004888 |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 3.75e-03 | 14 | 132 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 3.75e-03 | 14 | 132 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | palmitoyl hydrolase activity | 3.75e-03 | 14 | 132 | 2 | GO:0098599 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 4.30e-03 | 15 | 132 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 4.30e-03 | 15 | 132 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC9A9 SLC10A3 OTOP3 SLC30A3 SLC9C2 SLC1A6 SLC22A1 ATP2C2 PKD1 SLC39A6 SLC24A1 | 4.62e-03 | 664 | 132 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 4.90e-03 | 16 | 132 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 4.90e-03 | 16 | 132 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 5.53e-03 | 17 | 132 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.61e-03 | 171 | 132 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 6.19e-03 | 18 | 132 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 6.63e-03 | 178 | 132 | 5 | GO:0015399 | |
| GeneOntologyBiologicalProcess | peptide modification | 3.27e-07 | 10 | 132 | 4 | GO:0031179 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 3.72e-06 | 142 | 132 | 8 | GO:0006690 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 5.28e-06 | 69 | 132 | 6 | GO:0170038 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 5.74e-06 | 70 | 132 | 6 | GO:0170034 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | NPC1 ABCC1 ACADL ACLY ACOX1 PTGR2 ACAD10 UROC1 GGT2P GGT1 GGT3P CES2 MTOR UGT2A3 GLUD1 GLUD2 HSD17B12 C3 ALOXE3 PYCR2 | 9.45e-06 | 1035 | 132 | 20 | GO:0019752 |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 1.00e-05 | 77 | 132 | 6 | GO:1901607 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | NPC1 ABCC1 ACADL ACLY ACOX1 PTGR2 ACAD10 UROC1 GGT2P GGT1 GGT3P CES2 MTOR UGT2A3 GLUD1 GLUD2 HSD17B12 C3 ALOXE3 PYCR2 | 1.30e-05 | 1058 | 132 | 20 | GO:0043436 |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 1.40e-05 | 8 | 132 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | NPC1 ABCC1 ACADL ACLY ACOX1 PTGR2 ACAD10 UROC1 GGT2P GGT1 GGT3P CES2 MTOR UGT2A3 GLUD1 GLUD2 HSD17B12 C3 ALOXE3 PYCR2 | 1.41e-05 | 1064 | 132 | 20 | GO:0006082 |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 1.89e-05 | 86 | 132 | 6 | GO:0008652 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 2.98e-05 | 10 | 132 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 4.07e-05 | 11 | 132 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 5.40e-05 | 12 | 132 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 8.99e-05 | 37 | 132 | 4 | GO:0042219 | |
| GeneOntologyBiologicalProcess | glutamate metabolic process | 9.99e-05 | 38 | 132 | 4 | GO:0006536 | |
| GeneOntologyBiologicalProcess | positive regulation of activation of membrane attack complex | 1.21e-04 | 3 | 132 | 2 | GO:0001970 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 1.22e-04 | 172 | 132 | 7 | GO:0043604 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 1.35e-04 | 16 | 132 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.35e-04 | 41 | 132 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | ACADL ACLY GGT2P GGT1 GGT3P GLUD1 GLUD2 HSD17B12 ALOXE3 PYCR2 | 1.50e-04 | 374 | 132 | 10 | GO:0046394 |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | ACADL ACLY GGT2P GGT1 GGT3P GLUD1 GLUD2 HSD17B12 ALOXE3 PYCR2 | 1.60e-04 | 377 | 132 | 10 | GO:0016053 |
| GeneOntologyBiologicalProcess | glutamine family amino acid metabolic process | 1.63e-04 | 80 | 132 | 5 | GO:0009064 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC1 SLC9A9 SPG7 SLCO4A1 CASR FLVCR2 OTOP3 SLC22A24 SLC30A3 SLC9C2 SLC1A6 CLCN1 CLCN5 MTOR SLC22A1 ATP2C2 SLC22A10 PKD1 SLC39A6 SLC24A1 NNT | 1.69e-04 | 1374 | 132 | 21 | GO:0006811 |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | ACADL ACLY ACOX1 PTGR2 ACAD10 GGT1 CES2 MTOR HSD17B12 C3 ALOXE3 | 1.89e-04 | 461 | 132 | 11 | GO:0006631 |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 1.91e-04 | 185 | 132 | 7 | GO:0170039 | |
| GeneOntologyBiologicalProcess | tricarboxylic acid metabolic process | 1.95e-04 | 18 | 132 | 3 | GO:0072350 | |
| GeneOntologyBiologicalProcess | glutamine family amino acid biosynthetic process | 1.95e-04 | 18 | 132 | 3 | GO:0009084 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 2.05e-04 | 84 | 132 | 5 | GO:0006518 | |
| GeneOntologyBiologicalProcess | regulation of activation of membrane attack complex | 2.42e-04 | 4 | 132 | 2 | GO:0001969 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | NPC1 ACADL ACLY ACOX1 PTGR2 ACAD10 UROC1 GGT1 CES2 MTOR UGT2A3 HSD17B12 C3 ALOXE3 | 2.51e-04 | 731 | 132 | 14 | GO:0032787 |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 2.70e-04 | 20 | 132 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 3.13e-04 | 21 | 132 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 3.42e-04 | 52 | 132 | 4 | GO:1901570 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 3.61e-04 | 22 | 132 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 3.61e-04 | 22 | 132 | 3 | GO:0019370 | |
| GeneOntologyBiologicalProcess | lipoprotein metabolic process | 3.71e-04 | 147 | 132 | 6 | GO:0042157 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 3.90e-04 | 208 | 132 | 7 | GO:0170033 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to microtubule | 4.01e-04 | 5 | 132 | 2 | GO:1902817 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to microtubule | 4.01e-04 | 5 | 132 | 2 | GO:1902816 | |
| GeneOntologyBiologicalProcess | glutamate biosynthetic process | 4.01e-04 | 5 | 132 | 2 | GO:0006537 | |
| GeneOntologyBiologicalProcess | amide metabolic process | ACLY BACE1 UROC1 ABCA8 GGT2P GGT1 GGT3P MEP1A MTOR HSD17B12 ALOXE3 | 4.53e-04 | 511 | 132 | 11 | GO:0043603 |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC1 SLCO4A1 CASR SLC10A3 SLC22A24 CR1 SLC1A6 NF1 SLC22A1 SLC22A10 SLC39A6 | 4.83e-04 | 515 | 132 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 5.32e-04 | 25 | 132 | 3 | GO:0009070 | |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 6.00e-04 | 6 | 132 | 2 | GO:0001905 | |
| GeneOntologyBiologicalProcess | xenobiotic transport across blood-brain barrier | 6.00e-04 | 6 | 132 | 2 | GO:1990962 | |
| GeneOntologyBiologicalProcess | response to aluminum ion | 6.00e-04 | 6 | 132 | 2 | GO:0010044 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | ABCC1 ACADL PIGK ACLY ABCA8 GGT2P GGT1 GGT3P MTOR SERINC4 PIGW HSD17B12 C3 ALOXE3 | 7.23e-04 | 813 | 132 | 14 | GO:0008610 |
| GeneOntologyBiologicalProcess | dicarboxylic acid metabolic process | 7.41e-04 | 111 | 132 | 5 | GO:0043648 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5T1 OR7A5 NTRK1 BACE1 OR1F2P CASR OR8H1 OR14C36 OR10Z1 OR1N2 PTPRQ PKD1 TAS1R2 | 7.48e-04 | 722 | 132 | 13 | GO:0051606 |
| GeneOntologyCellularComponent | basal plasma membrane | ABCC1 EPPK1 SLCO4A1 CASR CR1 AQP5 ABCA8 SLC22A1 ATP2C2 SLC22A10 PTPRQ PKD1 SLC14A2 | 4.34e-07 | 354 | 133 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | ABCC1 EPPK1 SLCO4A1 CASR CR1 AQP5 ABCA8 SLC22A1 ATP2C2 SLC22A10 PTPRQ PKD1 SLC14A2 | 9.08e-07 | 378 | 133 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCC1 EPPK1 SLCO4A1 CASR CR1 ABCA8 SLC22A1 ATP2C2 SLC22A10 PKD1 SLC14A2 | 6.55e-06 | 320 | 133 | 11 | GO:0016323 |
| GeneOntologyCellularComponent | glutamatergic synapse | ABHD17A WNT7A ZDHHC5 CASR CAMK1 SLC30A3 ZDHHC8 TENM2 SLC1A6 AP2M1 NF1 ABHD17B NRXN1 MTOR TNR | 2.22e-04 | 817 | 133 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic recycling endosome membrane | 5.93e-04 | 6 | 133 | 2 | GO:0098944 | |
| MousePheno | abnormal circulating glutathione level | 3.84e-06 | 5 | 103 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 3.84e-06 | 5 | 103 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 3.84e-06 | 5 | 103 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 3.84e-06 | 5 | 103 | 3 | MP:0012606 | |
| MousePheno | anovulation | 3.97e-06 | 33 | 103 | 5 | MP:0008869 | |
| MousePheno | decreased circulating cysteine level | 1.33e-05 | 7 | 103 | 3 | MP:0030626 | |
| MousePheno | decreased cysteine level | 2.12e-05 | 8 | 103 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 2.12e-05 | 8 | 103 | 3 | MP:0004932 | |
| MousePheno | abnormal spine curvature | 2.20e-05 | 318 | 103 | 11 | MP:0004174 | |
| MousePheno | nervous | 3.16e-05 | 9 | 103 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 4.49e-05 | 10 | 103 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 4.49e-05 | 10 | 103 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 4.49e-05 | 10 | 103 | 3 | MP:0005158 | |
| MousePheno | kyphosis | 4.79e-05 | 229 | 103 | 9 | MP:0000160 | |
| MousePheno | aciduria | 5.11e-05 | 55 | 103 | 5 | MP:0010028 | |
| MousePheno | aminoaciduria | 5.73e-05 | 29 | 103 | 4 | MP:0003311 | |
| MousePheno | abnormal circulating cysteine level | 6.14e-05 | 11 | 103 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 6.14e-05 | 11 | 103 | 3 | MP:0011130 | |
| MousePheno | abnormal cysteine level | 1.05e-04 | 13 | 103 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 1.05e-04 | 13 | 103 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 1.05e-04 | 13 | 103 | 3 | MP:0012603 | |
| MousePheno | absent corpus luteum | 1.23e-04 | 66 | 103 | 5 | MP:0001134 | |
| MousePheno | priapism | 1.33e-04 | 14 | 103 | 3 | MP:0003415 | |
| MousePheno | decreased tertiary ovarian follicle number | 1.88e-04 | 39 | 103 | 4 | MP:0011129 | |
| MousePheno | abnormal copulatory plug deposition | 2.03e-04 | 16 | 103 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 2.03e-04 | 16 | 103 | 3 | MP:0008477 | |
| MousePheno | hindlimb paralysis | 2.88e-04 | 79 | 103 | 5 | MP:0000755 | |
| MousePheno | failure of superovulation | 2.93e-04 | 18 | 103 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 2.93e-04 | 18 | 103 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 2.93e-04 | 18 | 103 | 3 | MP:0009093 | |
| MousePheno | absent estrous cycle | 3.01e-04 | 44 | 103 | 4 | MP:0009009 | |
| MousePheno | small ovary | 3.42e-04 | 178 | 103 | 7 | MP:0001127 | |
| MousePheno | increased circulating growth hormone level | 3.45e-04 | 19 | 103 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 3.45e-04 | 19 | 103 | 3 | MP:0031627 | |
| MousePheno | limb paralysis | 3.63e-04 | 83 | 103 | 5 | MP:0013147 | |
| MousePheno | abnormal tertiary ovarian follicle number | 3.89e-04 | 47 | 103 | 4 | MP:0011127 | |
| MousePheno | small vertebrae | 5.40e-04 | 22 | 103 | 3 | MP:0004610 | |
| MousePheno | abnormal cholesterol level | NPC1 SLC9A9 DMXL2 PLVAP KCTD19 TMEM51 RNF25 SLC10A3 FLVCR2 ABCA8 CES2 CLCN1 NRXN1 MTOR PYCR2 NNT | 5.78e-04 | 867 | 103 | 16 | MP:0003947 |
| MousePheno | small uterus | 5.83e-04 | 92 | 103 | 5 | MP:0002637 | |
| MousePheno | increased growth hormone level | 6.18e-04 | 23 | 103 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 6.18e-04 | 23 | 103 | 3 | MP:0001121 | |
| MousePheno | abnormal sterol level | NPC1 SLC9A9 DMXL2 PLVAP KCTD19 TMEM51 RNF25 SLC10A3 FLVCR2 ABCA8 CES2 CLCN1 NRXN1 MTOR PYCR2 NNT | 6.79e-04 | 880 | 103 | 16 | MP:0012224 |
| MousePheno | abnormal copulation behavior | 7.03e-04 | 24 | 103 | 3 | MP:0009697 | |
| MousePheno | abnormal ovulation | 7.42e-04 | 97 | 103 | 5 | MP:0001928 | |
| MousePheno | abnormal hippocampus morphology | 7.47e-04 | 331 | 103 | 9 | MP:0000807 | |
| MousePheno | abnormal tertiary ovarian follicle morphology | 8.14e-04 | 57 | 103 | 4 | MP:0009363 | |
| MousePheno | disproportionate dwarf | 8.14e-04 | 57 | 103 | 4 | MP:0002427 | |
| MousePheno | abnormal temporal lobe morphology | 8.49e-04 | 337 | 103 | 9 | MP:0000801 | |
| MousePheno | decreased bone mass | 8.52e-04 | 100 | 103 | 5 | MP:0004016 | |
| MousePheno | nuclear cataract | 8.93e-04 | 26 | 103 | 3 | MP:0010254 | |
| MousePheno | abnormal urine amino acid level | 9.27e-04 | 59 | 103 | 4 | MP:0011468 | |
| MousePheno | decreased circulating gonadotropin level | 9.88e-04 | 60 | 103 | 4 | MP:0003363 | |
| MousePheno | abnormal circulating cholesterol level | NPC1 SLC9A9 DMXL2 PLVAP KCTD19 TMEM51 RNF25 SLC10A3 FLVCR2 ABCA8 CLCN1 NRXN1 MTOR PYCR2 NNT | 9.90e-04 | 823 | 103 | 15 | MP:0000180 |
| MousePheno | decreased circulating insulin-like growth factor I level | 1.05e-03 | 61 | 103 | 4 | MP:0004701 | |
| MousePheno | impaired ovarian folliculogenesis | 1.05e-03 | 61 | 103 | 4 | MP:0001129 | |
| MousePheno | increased cholesterol level | NPC1 SLC9A9 PLVAP KCTD19 TMEM51 RNF25 SLC10A3 FLVCR2 CES2 MTOR NNT | 1.16e-03 | 502 | 103 | 11 | MP:0003982 |
| Domain | Kelch_1 | 5.60e-07 | 70 | 130 | 7 | PF01344 | |
| Domain | Kelch_1 | 5.60e-07 | 70 | 130 | 7 | IPR006652 | |
| Domain | - | 9.78e-07 | 48 | 130 | 6 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 2.22e-06 | 55 | 130 | 6 | IPR015915 | |
| Domain | FAT | 6.49e-06 | 6 | 130 | 3 | PS51189 | |
| Domain | FATC | 6.49e-06 | 6 | 130 | 3 | PS51190 | |
| Domain | FAT | 6.49e-06 | 6 | 130 | 3 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 6.49e-06 | 6 | 130 | 3 | IPR003151 | |
| Domain | FATC_dom | 6.49e-06 | 6 | 130 | 3 | IPR003152 | |
| Domain | PIK_FAT | 6.49e-06 | 6 | 130 | 3 | IPR014009 | |
| Domain | FATC | 6.49e-06 | 6 | 130 | 3 | SM01343 | |
| Domain | ELFV_dehydrog_N | 4.81e-05 | 2 | 130 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 4.81e-05 | 2 | 130 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 4.81e-05 | 2 | 130 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 4.81e-05 | 2 | 130 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 4.81e-05 | 2 | 130 | 2 | PF00208 | |
| Domain | NAD_bind_Glu_DH | 4.81e-05 | 2 | 130 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 4.81e-05 | 2 | 130 | 2 | PS00074 | |
| Domain | ELFV_dehydrog | 4.81e-05 | 2 | 130 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 4.81e-05 | 2 | 130 | 2 | IPR033524 | |
| Domain | Kelch | 5.16e-05 | 58 | 130 | 5 | SM00612 | |
| Domain | - | 8.96e-05 | 13 | 130 | 3 | 1.10.540.10 | |
| Domain | AcylCoA_DH/ox_N | 8.96e-05 | 13 | 130 | 3 | IPR013786 | |
| Domain | MFS | 1.08e-04 | 108 | 130 | 6 | PS50850 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 1.41e-04 | 15 | 130 | 3 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 1.41e-04 | 15 | 130 | 3 | IPR009100 | |
| Domain | Acyl-CoA_dh_M | 1.41e-04 | 15 | 130 | 3 | PF02770 | |
| Domain | - | 1.73e-04 | 16 | 130 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.73e-04 | 16 | 130 | 3 | SM00146 | |
| Domain | AcylCo_DH/oxidase_C | 1.73e-04 | 16 | 130 | 3 | IPR009075 | |
| Domain | - | 1.82e-04 | 169 | 130 | 7 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 2.10e-04 | 173 | 130 | 7 | IPR016040 | |
| Domain | BTB-kelch_protein | 2.24e-04 | 43 | 130 | 4 | IPR017096 | |
| Domain | PI3_PI4_kinase | 2.49e-04 | 18 | 130 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 2.49e-04 | 18 | 130 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.49e-04 | 18 | 130 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 2.49e-04 | 18 | 130 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 2.49e-04 | 18 | 130 | 3 | PS50290 | |
| Domain | ABC_tran | 3.44e-04 | 48 | 130 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.44e-04 | 48 | 130 | 4 | PS50893 | |
| Domain | MFS_dom | 3.51e-04 | 134 | 130 | 6 | IPR020846 | |
| Domain | ABC_TRANSPORTER_1 | 3.73e-04 | 49 | 130 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 4.03e-04 | 50 | 130 | 4 | IPR003439 | |
| Domain | FATC | 4.74e-04 | 5 | 130 | 2 | PF02260 | |
| Domain | AAA | 5.15e-04 | 144 | 130 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 5.15e-04 | 144 | 130 | 6 | IPR003593 | |
| Domain | ABC_membrane | 5.99e-04 | 24 | 130 | 3 | PF00664 | |
| Domain | Gal_Oxase/kelch_b-propeller | 7.58e-04 | 59 | 130 | 4 | IPR011043 | |
| Domain | BACK | 8.08e-04 | 60 | 130 | 4 | SM00875 | |
| Domain | BACK | 8.60e-04 | 61 | 130 | 4 | IPR011705 | |
| Domain | BACK | 8.60e-04 | 61 | 130 | 4 | PF07707 | |
| Domain | ABC_TM1F | 9.50e-04 | 28 | 130 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 9.50e-04 | 28 | 130 | 3 | IPR011527 | |
| Domain | GGT_peptidase | 9.87e-04 | 7 | 130 | 2 | IPR000101 | |
| Domain | G_glu_transpept | 9.87e-04 | 7 | 130 | 2 | PF01019 | |
| Domain | G_GLU_TRANSPEPTIDASE | 9.87e-04 | 7 | 130 | 2 | PS00462 | |
| Domain | Plexin_repeat | 1.41e-03 | 32 | 130 | 3 | IPR002165 | |
| Domain | PSI | 1.41e-03 | 32 | 130 | 3 | PF01437 | |
| Domain | Cl-channel_core | 1.68e-03 | 9 | 130 | 2 | IPR014743 | |
| Domain | - | 1.68e-03 | 9 | 130 | 2 | 1.10.3080.10 | |
| Domain | Hydrolase_4 | 1.68e-03 | 9 | 130 | 2 | IPR022742 | |
| Domain | Voltage_CLC | 1.68e-03 | 9 | 130 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.68e-03 | 9 | 130 | 2 | IPR001807 | |
| Domain | Hydrolase_4 | 1.68e-03 | 9 | 130 | 2 | PF12146 | |
| Domain | MFS_1 | 2.05e-03 | 77 | 130 | 4 | PF07690 | |
| Domain | MFS | 2.05e-03 | 77 | 130 | 4 | IPR011701 | |
| Domain | ACYL_COA_DH_1 | 2.09e-03 | 10 | 130 | 2 | PS00072 | |
| Domain | ACYL_COA_DH_2 | 2.09e-03 | 10 | 130 | 2 | PS00073 | |
| Domain | RWD | 2.09e-03 | 10 | 130 | 2 | PS50908 | |
| Domain | RWD | 2.54e-03 | 11 | 130 | 2 | SM00591 | |
| Domain | Acyl-CoA_dh_N | 2.54e-03 | 11 | 130 | 2 | PF02771 | |
| Domain | RWD | 2.54e-03 | 11 | 130 | 2 | PF05773 | |
| Domain | Cation/H_exchanger_CPA1 | 2.54e-03 | 11 | 130 | 2 | IPR018422 | |
| Domain | CRAL_TRIO_2 | 3.03e-03 | 12 | 130 | 2 | PF13716 | |
| Domain | RWD-domain | 3.03e-03 | 12 | 130 | 2 | IPR006575 | |
| Domain | ABC_transporter_CS | 3.10e-03 | 42 | 130 | 3 | IPR017871 | |
| Domain | PSI | 3.54e-03 | 44 | 130 | 3 | IPR016201 | |
| Domain | Acyl-CoA_dh_1 | 3.57e-03 | 13 | 130 | 2 | PF00441 | |
| Domain | NCD3G | 3.57e-03 | 13 | 130 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 3.57e-03 | 13 | 130 | 2 | IPR011500 | |
| Domain | PSI | 4.02e-03 | 46 | 130 | 3 | SM00423 | |
| Domain | Na_H_Exchanger | 4.14e-03 | 14 | 130 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 4.14e-03 | 14 | 130 | 2 | IPR006153 | |
| Domain | GPCR_3_CS | 4.14e-03 | 14 | 130 | 2 | IPR017979 | |
| Domain | PI3/4_kinase_CS | 4.76e-03 | 15 | 130 | 2 | IPR018936 | |
| Domain | BTB | 5.26e-03 | 160 | 130 | 5 | PS50097 | |
| Domain | MAM_1 | 5.41e-03 | 16 | 130 | 2 | PS00740 | |
| Domain | - | 5.68e-03 | 52 | 130 | 3 | 2.60.120.290 | |
| Domain | CUB | 5.99e-03 | 53 | 130 | 3 | PS01180 | |
| Domain | EGF | 6.08e-03 | 235 | 130 | 6 | SM00181 | |
| Domain | EGF_3 | 6.08e-03 | 235 | 130 | 6 | PS50026 | |
| Domain | MAM | 6.11e-03 | 17 | 130 | 2 | SM00137 | |
| Domain | MAM | 6.84e-03 | 18 | 130 | 2 | PF00629 | |
| Domain | LH2 | 6.84e-03 | 18 | 130 | 2 | SM00308 | |
| Domain | MAM_dom | 6.84e-03 | 18 | 130 | 2 | IPR000998 | |
| Domain | MAM_2 | 6.84e-03 | 18 | 130 | 2 | PS50060 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 ABCC1 SLC9A9 SPG7 SLCO4A1 SLC30A3 ZDHHC8 SLC9C2 AQP5 SLC1A6 ABCA8 AP2M1 CLCN1 CLCN5 ABCB9 SLC22A1 ATP2C2 SLC39A6 SLC24A1 SLC14A2 | 5.06e-08 | 736 | 93 | 20 | M27287 |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | ABCC1 ACADL ACLY ACOX1 ACAD10 GGT2P GGT1 GGT3P HSD17B12 ALOXE3 | 1.70e-07 | 170 | 93 | 10 | MM15573 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 ABCC1 SLC9A9 SPG7 SLCO4A1 ZDHHC8 AQP5 SLC1A6 ABCA8 AP2M1 CLCN1 CLCN5 ABCB9 SLC22A1 ATP2C2 SLC39A6 SLC24A1 SLC14A2 | 3.97e-07 | 681 | 93 | 18 | MM14985 |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 2.30e-06 | 33 | 93 | 5 | MM15963 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 2.35e-06 | 176 | 93 | 9 | M27854 | |
| Pathway | REACTOME_DRUG_ADME | 1.33e-05 | 119 | 93 | 7 | MM15692 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.02e-05 | 25 | 93 | 4 | MM14858 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 4.98e-05 | 61 | 93 | 5 | MM14861 | |
| Pathway | REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM | 9.60e-05 | 14 | 93 | 3 | MM15570 | |
| Pathway | REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM | 9.60e-05 | 14 | 93 | 3 | M27851 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.22e-04 | 39 | 93 | 4 | MM15695 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 1.46e-04 | 16 | 93 | 3 | MM14680 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.97e-04 | 44 | 93 | 4 | M11911 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC9A9 SLCO4A1 SLC30A3 SLC1A6 SLC22A1 SLC39A6 SLC24A1 SLC14A2 | 2.37e-04 | 249 | 93 | 8 | M5988 |
| Pathway | WP_EICOSANOID_SYNTHESIS | 3.91e-04 | 22 | 93 | 3 | MM15961 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 5.09e-04 | 24 | 93 | 3 | MM17249 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 6.12e-04 | 59 | 93 | 4 | M27140 | |
| Pathway | WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION | 6.35e-04 | 6 | 93 | 2 | M39820 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 6.47e-04 | 26 | 93 | 3 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 7.25e-04 | 27 | 93 | 3 | MM15908 | |
| Pathway | REACTOME_DRUG_ADME | 7.63e-04 | 109 | 93 | 5 | M45012 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M | 8.85e-04 | 7 | 93 | 2 | M47574 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 9.89e-04 | 238 | 93 | 7 | MM15076 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 5.47e-08 | 3 | 133 | 3 | 2573352 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 23615310 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 11003618 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 10392451 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 5.44e-07 | 5 | 133 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 5.44e-07 | 5 | 133 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 5.44e-07 | 5 | 133 | 3 | 11089562 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 5.44e-07 | 5 | 133 | 3 | 12225953 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 7775425 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 9139708 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 5.44e-07 | 5 | 133 | 3 | 9546365 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 5.44e-07 | 5 | 133 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 5.44e-07 | 5 | 133 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 5.44e-07 | 5 | 133 | 3 | 24698228 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 5.44e-07 | 5 | 133 | 3 | 18063838 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 5.44e-07 | 5 | 133 | 3 | 11095909 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 7641802 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 9627710 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 12453183 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 2891746 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 5.44e-07 | 5 | 133 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 5.44e-07 | 5 | 133 | 3 | 8566783 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 30591459 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 5.44e-07 | 5 | 133 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 5.44e-07 | 5 | 133 | 3 | 19760322 | |
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 6.00e-07 | 18 | 133 | 4 | 17097888 | |
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 1.08e-06 | 6 | 133 | 3 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 1.08e-06 | 6 | 133 | 3 | 8104871 | |
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 11463821 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 25326709 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 12163373 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 22242126 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 17363454 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 8663190 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 1.89e-06 | 7 | 133 | 3 | 32284594 | |
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 36685533 | ||
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 1.89e-06 | 7 | 133 | 3 | 1968405 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ABCC1 TMEM51 ZDHHC5 SLCO4A1 CDCP1 ZDHHC8 KLHL38 AP2M1 NF1 MTOR WDR20 PLXNA2 | 2.09e-06 | 569 | 133 | 12 | 30639242 |
| Pubmed | NPC1 EPPK1 TMEM51 SCYL1 PTGR2 SLC10A3 TRIM21 CHEK1 AQP5 NF1 MDN1 ARSL MTOR UGT2A3 WDR20 HSD17B12 C3 RPGR | 2.28e-06 | 1293 | 133 | 18 | 15342556 | |
| Pubmed | GluD1 is a signal transduction device disguised as an ionotropic receptor. | 3.02e-06 | 8 | 133 | 3 | 34135511 | |
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 4.51e-06 | 29 | 133 | 4 | 22424930 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 EPPK1 SPG7 ZDHHC5 SLCO4A1 SLC10A3 TRRAP ZDHHC8 MDN1 MEGF8 MTOR GLI1 PKD1 DIP2C PIGW MCF2L | 5.34e-06 | 1105 | 133 | 16 | 35748872 |
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 6.43e-06 | 10 | 133 | 3 | 18160036 | |
| Pubmed | 6.43e-06 | 10 | 133 | 3 | 23863468 | ||
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 8.82e-06 | 11 | 133 | 3 | 20427287 | |
| Pubmed | NPC1 ABHD17A ABCC1 PIGK ACLY ACOX1 MFSD6 ZDHHC5 SCYL1 ERGIC2 NF1 MDN1 CLCN5 ABHD17B MTOR NNT | 1.06e-05 | 1168 | 133 | 16 | 19946888 | |
| Pubmed | 1.17e-05 | 12 | 133 | 3 | 7896292 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 34173171 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 28621566 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25180444 | ||
| Pubmed | Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells. | 1.45e-05 | 2 | 133 | 2 | 28031537 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 32078638 | ||
| Pubmed | Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? | 1.45e-05 | 2 | 133 | 2 | 17102641 | |
| Pubmed | Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. | 1.45e-05 | 2 | 133 | 2 | 23844225 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 10382758 | ||
| Pubmed | Mangiferin induces cell cycle arrest at G2/M phase through ATR-Chk1 pathway in HL-60 leukemia cells. | 1.45e-05 | 2 | 133 | 2 | 25966274 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21383502 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23595828 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21621574 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31441116 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 28911206 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 30841479 | ||
| Pubmed | Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer. | 1.45e-05 | 2 | 133 | 2 | 29138515 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24327542 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22875990 | ||
| Pubmed | Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. | 1.45e-05 | 2 | 133 | 2 | 12738771 | |
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 1.45e-05 | 2 | 133 | 2 | 15578726 | |
| Pubmed | Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes. | 1.45e-05 | 2 | 133 | 2 | 15044002 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25349208 | ||
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 1.45e-05 | 2 | 133 | 2 | 22138648 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25904336 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 34220417 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25280803 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 18550533 | ||
| Pubmed | Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. | 1.45e-05 | 2 | 133 | 2 | 26241911 | |
| Pubmed | Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities. | 1.45e-05 | 2 | 133 | 2 | 26748709 | |
| Pubmed | ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress. | 1.45e-05 | 2 | 133 | 2 | 19119425 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23733185 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21446915 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31209037 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 38060673 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23216249 | ||
| Pubmed | DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1. | 1.45e-05 | 2 | 133 | 2 | 25460505 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25049274 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24593767 | ||
| Pubmed | The nucleolus stress response is coupled to an ATR-Chk1-mediated G2 arrest. | 1.45e-05 | 2 | 133 | 2 | 23447702 | |
| Pubmed | Potentiation of neuronal activity by tonic GluD1 current in brain slices. | 1.45e-05 | 2 | 133 | 2 | 37154294 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22924626 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12791699 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 11032875 | ||
| Interaction | GLUD2 interactions | 2.04e-06 | 34 | 125 | 5 | int:GLUD2 | |
| GeneFamily | Solute carriers | SLC9A9 SLC25A33 SLCO4A1 SLC25A30 SLC10A3 FLVCR2 SLC22A24 SLC30A3 SLC9C2 SLC1A6 SLC22A1 SLC22A10 SLC39A6 SLC24A1 SLC14A2 | 1.15e-09 | 395 | 91 | 15 | 752 |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 3.40e-05 | 13 | 91 | 3 | 564 | |
| GeneFamily | Kelch like|BTB domain containing | 5.81e-05 | 42 | 91 | 4 | 617 | |
| GeneFamily | Chloride voltage-gated channels | 1.10e-03 | 10 | 91 | 2 | 302 | |
| GeneFamily | Acyl-CoA dehydrogenase family | 1.34e-03 | 11 | 91 | 2 | 974 | |
| GeneFamily | ATP binding cassette subfamily C | 1.89e-03 | 13 | 91 | 2 | 807 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.69e-03 | 134 | 91 | 4 | 861 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 4.94e-03 | 21 | 91 | 2 | 680 | |
| GeneFamily | Abhydrolase domain containing | 5.42e-03 | 22 | 91 | 2 | 4 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 6.43e-03 | 24 | 91 | 2 | 76 | |
| Computational | Neighborhood of FANCG | 1.71e-04 | 167 | 76 | 7 | MORF_FANCG | |
| Computational | Neighborhood of FDXR | 1.86e-04 | 226 | 76 | 8 | MORF_FDXR | |
| Computational | Neighborhood of LMO1 | 4.83e-04 | 52 | 76 | 4 | MORF_LMO1 | |
| Computational | Neighborhood of TNFRSF25 | 5.57e-04 | 266 | 76 | 8 | MORF_TNFRSF25 | |
| Computational | Neighborhood of JAK3 | 5.73e-04 | 96 | 76 | 5 | MORF_JAK3 | |
| Drug | fluorocitrate | 4.59e-07 | 27 | 133 | 5 | CID000107647 | |
| Drug | methyl benzoquate | 7.76e-07 | 4 | 133 | 3 | CID000026383 | |
| Drug | pentenoic acid | 7.76e-07 | 4 | 133 | 3 | CID000012299 | |
| Drug | 2 pc | 3.20e-06 | 18 | 133 | 4 | CID000440046 | |
| Drug | AC1NORN0 | 4.03e-06 | 19 | 133 | 4 | CID005118010 | |
| Drug | AC1L1AH5 | 5.00e-06 | 215 | 133 | 9 | CID000000986 | |
| Drug | thionicotinamide | 6.17e-06 | 21 | 133 | 4 | CID000737155 | |
| Drug | CoA group | NPC1 ACADL ACLY ACOX1 ACAD10 GGT1 GLUD1 GLUD2 PIGW C3 SLC14A2 NNT | 9.27e-06 | 433 | 133 | 12 | CID000000317 |
| Drug | isovaleryl-CoA | 1.45e-05 | 53 | 133 | 5 | CID000000810 | |
| Drug | 5-methylhex-4-enoyl-CoA | 1.60e-05 | 9 | 133 | 3 | CID009549328 | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 133 | 8 | 2718_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 2068_DN | |
| Drug | adipic acid | 2.25e-05 | 58 | 133 | 5 | CID000000196 | |
| Drug | methylenecyclopropylacetyl-CoA | 2.27e-05 | 10 | 133 | 3 | CID000162805 | |
| Drug | 4-cis-decenoyl-CoA | 2.27e-05 | 10 | 133 | 3 | CID006443609 | |
| Drug | glutarate | 2.85e-05 | 101 | 133 | 6 | CID000000743 | |
| Drug | palmitoylcarnitine | 3.02e-05 | 102 | 133 | 6 | CID000000461 | |
| Drug | phenyltriethoxysilane | 3.39e-05 | 2 | 133 | 2 | CID000013075 | |
| Drug | G-3SH | 3.39e-05 | 2 | 133 | 2 | CID000174237 | |
| Drug | iodoacetyldiethylstilbestrol | 3.39e-05 | 2 | 133 | 2 | CID006455327 | |
| Drug | methylmercuric bromide | 3.39e-05 | 2 | 133 | 2 | CID000068175 | |
| Drug | 5-methylisophthalate | 3.39e-05 | 2 | 133 | 2 | CID000068137 | |
| Drug | x 1 s | 3.39e-05 | 2 | 133 | 2 | CID000409694 | |
| Drug | AC1L193Y | 3.93e-05 | 65 | 133 | 5 | CID000000380 | |
| Drug | AC1NORN3 | 4.13e-05 | 12 | 133 | 3 | CID005118011 | |
| Drug | AC1NOS53 | 4.13e-05 | 12 | 133 | 3 | CID005118245 | |
| Drug | 2-pentynoyl-CoA | 4.13e-05 | 12 | 133 | 3 | CID000192250 | |
| Drug | malate | 4.51e-05 | 219 | 133 | 8 | CID000000525 | |
| Drug | sporidesmin | 5.34e-05 | 13 | 133 | 3 | CID000099596 | |
| Drug | phylloerythrin | 5.34e-05 | 13 | 133 | 3 | CID005480977 | |
| Drug | AC1NORMX | 5.34e-05 | 13 | 133 | 3 | CID005118009 | |
| Drug | AC1NPX1L | 6.77e-05 | 14 | 133 | 3 | CID005165851 | |
| Drug | CoA persulfide | 6.77e-05 | 14 | 133 | 3 | CID000174251 | |
| Drug | tetrachlorophenol | 6.77e-05 | 14 | 133 | 3 | CID000021013 | |
| Drug | T2-decenoyl-CoA | 8.42e-05 | 15 | 133 | 3 | CID000656483 | |
| Drug | AC1Q68ZE | 1.01e-04 | 79 | 133 | 5 | CID000000265 | |
| Drug | lenthionine | 1.01e-04 | 3 | 133 | 2 | CID000067521 | |
| Drug | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide | 1.01e-04 | 3 | 133 | 2 | ctd:C560580 | |
| Drug | mildiomycin | 1.01e-04 | 3 | 133 | 2 | CID000125665 | |
| Drug | methoxyethylmercury | 1.01e-04 | 3 | 133 | 2 | CID000115155 | |
| Drug | 4-methylumbelliferyl laurate | 1.01e-04 | 3 | 133 | 2 | CID000600674 | |
| Drug | methylmercuric iodide | 1.01e-04 | 3 | 133 | 2 | CID000067347 | |
| Drug | AC1L9DYZ | 1.03e-04 | 16 | 133 | 3 | CID000443062 | |
| Drug | 2-octynoyl-CoA | 1.25e-04 | 17 | 133 | 3 | CID000125964 | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.34e-04 | 191 | 133 | 7 | 4981_DN | |
| Drug | AC1L7AJI | 1.34e-04 | 256 | 133 | 8 | CID000003750 | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 1.43e-04 | 193 | 133 | 7 | 4394_DN | |
| Drug | DL-1,2-anhydro-myo-inositol | 1.50e-04 | 46 | 133 | 4 | CID000002859 | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3416_DN | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; PC3; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 3997_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 5537_DN | |
| Drug | oxaloacetate | 1.67e-04 | 198 | 133 | 7 | CID000000970 | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 4338_UP | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 7339_DN | |
| Drug | alpha-ketoglutaramate | 2.02e-04 | 4 | 133 | 2 | CID000000048 | |
| Drug | ureidoglycine | 2.02e-04 | 4 | 133 | 2 | CID000439649 | |
| Drug | Ivin | 2.02e-04 | 4 | 133 | 2 | CID000014083 | |
| Drug | 8-BDB-TADP | 2.02e-04 | 4 | 133 | 2 | CID000130791 | |
| Drug | cadina-3,9-diene | 2.02e-04 | 4 | 133 | 2 | CID000010657 | |
| Drug | AC1L9CUQ | 2.02e-04 | 4 | 133 | 2 | CID000442451 | |
| Drug | trimethylamine-carbomethoxyborane | 2.02e-04 | 4 | 133 | 2 | CID011953132 | |
| Drug | luxabendazole | 2.02e-04 | 4 | 133 | 2 | CID000072019 | |
| Drug | N-butylmaleimide | 2.02e-04 | 4 | 133 | 2 | CID000239780 | |
| Drug | alpha-methylglutamate | 2.02e-04 | 4 | 133 | 2 | CID000095440 | |
| Drug | 2b E2 | 2.02e-04 | 4 | 133 | 2 | CID005327076 | |
| Drug | AC1NQAAM | 2.05e-04 | 144 | 133 | 6 | CID005192834 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 2.57e-06 | 7 | 125 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 4.09e-06 | 8 | 125 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | gamma-glutamyltryptophan measurement | 5.33e-05 | 3 | 125 | 2 | EFO_0800671 | |
| Disease | fascioliasis (biomarker_via_orthology) | 5.33e-05 | 3 | 125 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | uric acid measurement | NTRK1 WNT7A ZDHHC5 PTGR2 ACAD10 SLC22A24 TENM2 GLUD1 SLC22A10 DIP2C SLC14A2 | 5.95e-05 | 610 | 125 | 11 | EFO_0004761 |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.06e-04 | 4 | 125 | 2 | DOID:898 (is_implicated_in) | |
| Disease | Intellectual Disability | 1.26e-04 | 447 | 125 | 9 | C3714756 | |
| Disease | Ataxia | 1.59e-04 | 25 | 125 | 3 | C0004134 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 2.64e-04 | 6 | 125 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | adipoylcarnitine (C6-DC) measurement | 2.64e-04 | 6 | 125 | 2 | EFO_0800380 | |
| Disease | Liver carcinoma | 3.20e-04 | 507 | 125 | 9 | C2239176 | |
| Disease | Large cell carcinoma of lung | 3.36e-04 | 32 | 125 | 3 | C0345958 | |
| Disease | Drug toxicity | 4.56e-04 | 84 | 125 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 4.56e-04 | 84 | 125 | 4 | C0041755 | |
| Disease | pantothenate measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0021034 | |
| Disease | Glioma | 5.21e-04 | 87 | 125 | 4 | C0017638 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 5.62e-04 | 157 | 125 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | social interaction measurement | 6.97e-04 | 94 | 125 | 4 | EFO_0009592 | |
| Disease | estrogen measurement | 7.84e-04 | 10 | 125 | 2 | EFO_0011007 | |
| Disease | brain ischemia (biomarker_via_orthology) | 9.47e-04 | 102 | 125 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.35e-03 | 13 | 125 | 2 | C1846647 | |
| Disease | Schizophrenia | NTRK1 BACE1 CHEK1 SLC30A3 TRRAP ZDHHC8 SLC1A6 NRXN1 MTOR MTNR1A PLXNA2 | 1.36e-03 | 883 | 125 | 11 | C0036341 |
| Disease | gamma-glutamylglutamate measurement | 1.57e-03 | 14 | 125 | 2 | EFO_0021137 | |
| Disease | Metastatic melanoma | 1.57e-03 | 54 | 125 | 3 | C0278883 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.80e-03 | 15 | 125 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Tremor, Rubral | 2.05e-03 | 16 | 125 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.05e-03 | 16 | 125 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.05e-03 | 16 | 125 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 2.05e-03 | 16 | 125 | 2 | C0240991 | |
| Disease | Abnormal coordination | 2.05e-03 | 16 | 125 | 2 | C0520966 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.05e-03 | 16 | 125 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Ataxia, Truncal | 2.05e-03 | 16 | 125 | 2 | C0427190 | |
| Disease | succinylcarnitine measurement | 2.05e-03 | 16 | 125 | 2 | EFO_0020020 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 2.32e-03 | 17 | 125 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | ovarian neoplasm | 2.58e-03 | 134 | 125 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 2.79e-03 | 137 | 125 | 4 | C1140680 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.04e-03 | 68 | 125 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Malignant Glioma | 3.30e-03 | 70 | 125 | 3 | C0555198 | |
| Disease | mixed gliomas | 3.30e-03 | 70 | 125 | 3 | C0259783 | |
| Disease | blood pressure | 3.89e-03 | 22 | 125 | 2 | EFO_0004325 | |
| Disease | urinary metabolite measurement | 3.96e-03 | 245 | 125 | 5 | EFO_0005116 | |
| Disease | carnitine measurement | 4.17e-03 | 76 | 125 | 3 | EFO_0010469 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLLFEGLRDGYHGTM | 781 | Q6UXC1 | |
| VGGSMIIGGIDHSLY | 231 | P56817 | |
| TMENFLGKSLHGLYG | 306 | P51690 | |
| FHQLMAGVVYLHGIG | 111 | O14757 | |
| GHLTGMVGTALYVSP | 896 | Q9P2K8 | |
| GPGFSIHSGIVMSYI | 131 | P28330 | |
| MVYGHLLQDSSGSFL | 741 | Q9H5V8 | |
| MYSSILVVGGGLMFH | 531 | Q9H981 | |
| HEGSLMALGFLIGYT | 766 | P41180 | |
| FSTTGMLHGIGKFIV | 326 | Q96RQ1 | |
| LHSIQGLYGLAQGAM | 1826 | Q8IYW2 | |
| GKGQGTLSVVTMYHA | 1336 | P01024 | |
| HLGGSTYRAVIFDMG | 36 | Q6JQN1 | |
| AVDLGQMSSFYIGLG | 121 | Q96GS6 | |
| HILTVGVGANIFMYG | 1181 | Q8TDJ6 | |
| RNHMFLYSVLGSILG | 871 | O75185 | |
| LGHLVGIYFTGCSMN | 171 | P55064 | |
| TYGQTLLIHGDGQMF | 431 | Q17RG1 | |
| HMVIYFTVALLGGGP | 196 | Q15622 | |
| HSMGIGVGLFLTIYN | 81 | A6NGU5 | |
| GAALGQMGIAYFSIV | 421 | Q7RTS5 | |
| PLGVFYRMHSVGGLV | 576 | Q7RTS5 | |
| YRMHSVGGLVEVYLG | 581 | Q7RTS5 | |
| ASQVAAGMVYLAGLH | 631 | P04629 | |
| QTGASLVTHFYPLMG | 3661 | Q9NU22 | |
| HGTTGILYMSAAVLQ | 96 | Q13021 | |
| LFLLGMLIIGSTYQH | 26 | O60721 | |
| YNGILAMVSHLVGGI | 1526 | O60303 | |
| QGLIYLMSTGLAHFT | 471 | Q9BYJ1 | |
| YFAGMTFAVVGILGH | 256 | Q9H3H5 | |
| LGLVLFMVYGNVHVS | 41 | Q9BX97 | |
| MVTITGHYLGAGSSV | 971 | O75051 | |
| AMAIINGSLYVFGGT | 211 | Q6PID8 | |
| SLLSGLVYAGMHTGS | 146 | Q8NHC7 | |
| LVYAGMHTGSTFQLP | 151 | Q8NHC7 | |
| GTSEMLALVIGHFIY | 456 | P09131 | |
| IHGGALVFGMASLYD | 146 | O00748 | |
| HVSGAVLTFGMGSLY | 121 | Q6UX65 | |
| HTASVLGNYMVVYGG | 451 | Q7Z7M0 | |
| AGSLYAIGGFAMIQL | 541 | O60662 | |
| GLMYISGGITHDTFQ | 446 | Q9P2J3 | |
| YLGAAHGLSSILQML | 231 | Q6ZV70 | |
| YGHLSIGTMSPSLGF | 121 | P08151 | |
| MIGGLFIYNHKGEVL | 1 | Q96CW1 | |
| IGHLQSLTFNGMAYI | 866 | Q9ULB1 | |
| GLAMLSVGIGIDYTH | 336 | Q6ZSS7 | |
| NILIYMTGHGGNGFL | 156 | Q92643 | |
| GSHLAVVLLFYGTIM | 241 | Q96R84 | |
| FVIAMLEGLKGGHTY | 1746 | Q9UMZ3 | |
| TGYLFGLGMTLVIFH | 151 | Q8NGY1 | |
| ESGGHLYLIMQLVSG | 86 | Q14012 | |
| LLGHGTRVGATYFMT | 1026 | O15118 | |
| HLTGVTIYHGTILFM | 256 | Q8NG75 | |
| YAQTEMGHGTHLRGL | 136 | Q15067 | |
| YHGVVKSMLGLGQLS | 1736 | Q13535 | |
| AISMGFGHFYGTIQI | 226 | Q9ULG6 | |
| HGSAYLTVQVMGELF | 131 | Q9NSI5 | |
| ILSGLMGDTVYTHFL | 191 | Q5SVS4 | |
| HGMATLLNKLYVIGG | 486 | Q53GT1 | |
| GGHVSLYLPGMTISY | 1861 | P17927 | |
| ATGGTLHMYQLEGLN | 731 | Q12873 | |
| VQGFGNVGLHSMRYL | 306 | P00367 | |
| GRLLGVGMEQLAYYH | 536 | P51795 | |
| GVLSMHGLTYGVIRV | 676 | Q9Y2E4 | |
| GYLIHALMGSIISNL | 271 | Q53GQ0 | |
| RFGHSAVVINGSMYI | 581 | Q5VV63 | |
| MYTLTVIVGLFLHAG | 341 | P48664 | |
| LVGMVVYTFTLNLGH | 386 | Q9UPI3 | |
| SMHLIAITGYDGNLG | 811 | O15068 | |
| TDSVLYQGLILHMGA | 356 | O15245 | |
| YQGLILHMGATSGNL | 361 | O15245 | |
| VQGFGNVGLHSMRYL | 306 | P49448 | |
| MGSHYFAQAGLELLG | 31 | Q8N769 | |
| HSMGIGVGLFLTIYN | 81 | P36268 | |
| GSGTTAHVGIMLYGV | 3131 | P98161 | |
| AHVGIMLYGVDSRSG | 3136 | P98161 | |
| ASHLLGVTIFYGTMI | 241 | Q8NGG4 | |
| HLTVVLLFYGSLMGV | 261 | Q8NGR9 | |
| VGLLGYSSHQGLMGF | 331 | P42345 | |
| ALGISQGIAVFGYSM | 1021 | P33527 | |
| MYHRVVSGLGFGASL | 206 | Q12947 | |
| TVDGMLGGYGHISSI | 26 | Q9BV86 | |
| MVTTFGLAGIVGYHT | 501 | Q13423 | |
| HTALITDIGLMYTFG | 306 | Q92834 | |
| VLELYSGVGGMHHAL | 6 | O14717 | |
| SFAGHLAGILVGLMY | 191 | Q8TEB9 | |
| FRFLHETGGAMVYGL | 46 | Q8IVB4 | |
| LFMAGSLLGGLIYGH | 151 | Q8N4F4 | |
| AGVLGFAATHNLYSM | 486 | Q96KG9 | |
| SGSGLLMAVYSVGKH | 166 | Q17RQ9 | |
| TIPFYGTMVNLQHVG | 361 | Q63ZE4 | |
| TGHFVLYGTMLGIKV | 366 | Q96BP3 | |
| GLYMLQLAGRGSAVH | 2411 | P58107 | |
| GLYMLQLAGRGSAVH | 4546 | P58107 | |
| DHTLLGQCTGAGYFM | 301 | Q16819 | |
| QMVIGFHGGLYDPLT | 2406 | Q9NT68 | |
| MSVGFIGAGQLAYAL | 1 | Q96C36 | |
| SVELHGTMKSYFGGL | 251 | Q8TBZ3 | |
| FGNALYSVGMTAVGL | 251 | Q9UQ90 | |
| ITSSMQGLGIIHAYG | 991 | Q96J65 | |
| GVLFLHNEGYSSMCG | 91 | Q96EM0 | |
| YPQVHLGTISGAGMV | 51 | Q9BSK2 | |
| GYVAIHMAGVQTGLY | 311 | Q7Z7B1 | |
| MLAYLGMATGIFIGH | 666 | Q13433 | |
| GMATGIFIGHYAENV | 671 | Q13433 | |
| MLGQFLHGVGATPLY | 231 | Q96BD0 | |
| MHSFIGQSGVITDLY | 211 | O94911 | |
| SILYYGGHLVISGQM | 426 | Q9NP78 | |
| AVDLGQMSSFYIGLG | 101 | Q5VST6 | |
| FVLGRSMGFIGHYLD | 1061 | P53396 | |
| VHSVLVMGYGGLTSL | 411 | Q8IZF4 | |
| VMGYGGLTSLFNLVV | 416 | Q8IZF4 | |
| FSLLGLHLAYVTSMG | 841 | P35523 | |
| GISSLHMVGYLGKNF | 21 | Q5W0Q7 | |
| GHYVGFSMVSLLLEL | 126 | A6NGC4 | |
| VYGIHVTMLLVGGLG | 116 | H0YL14 | |
| EQTLVMYSGHPLGLF | 151 | Q96N76 | |
| LGHVAKAGLGTAMLY | 101 | Q96BH1 | |
| GFYSMAGVGAVLLFH | 231 | A6NH21 | |
| YVSIASGGFMALQQH | 426 | Q9NUY8 | |
| HLMNGDTLSGVYPIF | 1141 | Q92752 | |
| HYALTAIGLGMLVLG | 11 | Q9NW97 | |
| NVDSGLMHSIGLGYH | 1156 | P21359 | |
| GMVSFYNITDHGSLI | 416 | P19474 | |
| GDYLLGGLFSLHANM | 31 | Q8TE23 | |
| AISSSMHSLYGLGLG | 221 | P50616 | |
| FMAGEVVGGYLAHSL | 86 | Q99726 | |
| AAAALHGYGGMNLTV | 91 | Q8N9L1 | |
| LTAHIMGVFGFGLLY | 156 | Q9C0B5 | |
| HLFLSLGMVYLRIGG | 11 | O00755 | |
| TKAFITHGGMNGIYE | 366 | Q6UWM9 | |
| LSAHMVGVVAFGLVY | 156 | Q9ULC8 | |
| SLSGFVIGHMAYNSV | 61 | Q5TAH2 | |
| HAGVYSTGLAMVGAI | 86 | Q9Y3S2 | |
| AIASGLHGYNGMLVG | 176 | Q15849 | |
| AGFHGYNGVLVGLLM | 641 | Q15849 | |
| LVDGHLSYFLGAIGM | 121 | Q8N8N7 | |
| MLGVHASASAIIQYG | 3031 | Q9Y4A5 | |
| YGLFAVVMHSGITIS | 576 | O94782 | |
| HSMGIGGGLFLTIYN | 81 | P19440 | |
| HRSIYVLGGMAVSSG | 331 | Q2WGJ6 | |
| IGHSIGSYFTLQMLK | 136 | Q9H6V9 | |
| GYLHCQVSGFLMGLS | 96 | P48039 |